Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült ÁllamokFázis nélkül

rTMS for Military TBI-related Depression

A legfontosabb adatok

Ki végzi
Henry M. Jackson Foundation for the Advancement of Military Medicine
Hol
Fort Belvoir, Fort Bliss és Palo Alto (Egyesült Államok)Mind a 3 helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
198 fő, tervezett
Kezdés
2024. dec. 16.
Várható befejezés
2026. dec. 31.
A vizsgálat típusa
Beavatkozással járó, 3 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Repetitive Transcranial Magnetic Stimulation (rTMS)
  • Sham rTMS
A regiszteradat frissítve
2026. április 29.

Ki vehet részt

Életkor
18 év – 55 év
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 26 feltétel megnézéseKevesebb

Ki vehet részt

  • Age 18-55 at the time of consent. Older individuals will not be enrolled in this initial trial for reasons of safety and expected reduced efficacy
  • Current or former US military service member eligible for care at a Military Treatment Facility (MTF) or Veterans Administration Medical Center (VAMC.)
  • Able to provide written, informed consent in English
  • Self-reported or medically diagnosed history of concussion (synonymous with "mild TBI.") >6 months, but <26 years prior to consent, defined based on the DoD/VA definition:; Positive Loss of Consciousness of <30 minutes as confirmed by the TBI Screener and/or medical records and/or; Positive Alteration of Consciousness of <24 hours as confirmed by the TBI Screener and/or medical records and/or; Positive Post-traumatic Amnesia of 0 to 1 day as confirmed by the TBI Screener and/or medical records; Note: Neuroimaging data or documentation from medical records is not required
  • Baseline MADRS >13 at the time of screening indicating at least mild-moderate depressive symptoms
  • Maintained a steady psychotropic medication regimen for six weeks and a steady behavioral therapy regimen for twelve weeks prior to enrollment in the study
  • Female participants with child-bearing potential must agree to use an effective method of birth control during the course of the study
  • Under the care of a primary care and/or behavioral health provider

Ki nem vehet részt

  • Elevated risk of seizures at the time of rTMS including any of the following:; History of unprovoked seizures; History of seizure within 24 hours of sustaining a concussion(s) or other head injury regardless of whether it was determined to have been related to concussion; Family history of two or more unprovoked seizures in a first degree relative (parent, sibling, or child); History of Moderate, Severe, or Penetrating TBI based on TBI Screener and/or medical records; Intracranial lesion (such as intracranial tumor or intraparenchymal hemorrhage) that, in the opinion of the investigators, would increase seizure risk; Currently taking medication or other substances (such as tricyclic antidepressants or neuroleptics) that, in the opinion of the investigator, lowers the seizure threshold
  • Severe claustrophobia interfering with medication/sedation-free 3T closed-bore MRI
  • Any implant, prosthesis or other permanent alteration of the body (such as implanted neurostimulators and medication pumps) that, in the opinion of the investigator, would be unsafe with MRI or TMS or that would produce an artifact that would compromise the integrity of data
  • Concomitant or lifetime history of receiving open-label TMS, due to issues preserving blinding
  • Concomitant or recent history (within 12 weeks prior to enrollment) of receiving other neurostimulatory treatment, including but not limited to transcranial direct current (tDCS), transcranial alternating current (tACS), alpha stim, or electroconvulsive therapy
  • Suicide attempt within six months prior to enrollment
  • Any other considerations that, in the opinion of the investigators, may adversely affect participant safety, participation, or the scientific validity of the data being collected (e.g., erratic or unreliable responses, inconsistent communication, inability to remain on a steady neurotropic medication and/or behavioral therapy regimen over the course of the Randomization phase of the study.)
  • History of severe or recent uncontrolled heart disease
  • Presence of a cardiac pacemaker or intracardiac lines
  • Presence of rapidly progressive illnesses such as late-stage cancer, neurodegenerative conditions, major organ failure, etc
  • History of Bipolar Disorder or Schizophrenia Spectrum Disorders
  • Current evidence of substance-induced mood disorder, active psychosis, or depression secondary to general medical illness other than TBI
  • Right upper extremity amputation or other condition precluding left motor threshold calibration
  • Contraindications to awake 3T MRI without contrast at the time of the Baseline MRI according to site radiology department criteria
  • Intracranial lesion that would produce an artifact that would compromise the integrity of rsfMRI data
  • Severe or uncontrolled substance use
  • Unable to complete timeline of study (e.g., planned hospitalization partway through the study period.)
  • Prisoner, or other legally restricted freedom of movement and participation

A fő feltételek kérdésként

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 55 év között vagy?

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • Alexander T. Augusta Military Medical CenterFort Belvoir, Egyesült ÁllamokContact: Vanessa Donahue, BSRésztvevőt keres
  • William Beaumont Army Medical CenterFort Bliss, Egyesült ÁllamokContact: Diana HernandezRésztvevőt keres
  • VA Palo Alto Health Care SystemPalo Alto, Egyesült ÁllamokContact: Rachel DieterichRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of this study is to investigate the efficacy, safety, and tolerability of two dorsolateral prefrontal cortex (DLPFC) repetitive transcranial magnetic stimulation (rTMS) protocols to alleviate symptoms of depression in United States (U.S.) military service members and veterans with a history of concussion/mild traumatic brain injury (TBI).

A vizsgálat 3 csoportja

  • Arm 1A vizsgált kezelés

    Active rTMS/Individualized Connectome Targeting (ICT)

    Kezelés: Repetitive Transcranial Magnetic Stimulation (rTMS)

  • Arm 2A vizsgált kezelés

    Active rTMS/resting state functional MRI (rsfMRI)-based targeting

    Kezelés: Repetitive Transcranial Magnetic Stimulation (rTMS)

  • Arm 3Színlelt kezelés, összehasonlításként

    Sham rTMS

    Kezelés: Sham rTMS

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
ADEPT: Adaptive Trial for the Treatment of Depressive Symptoms Associated With Concussion Using Repetitive Transcranial Magnetic Stimulation Protocols
Kérdések a feltételekről
Forrás: NCT05426967: ki vehet részt
Publikációk
A regiszteradat frissítve
2026. április 29.